lets learn the right use of powerpoint
DESCRIPTION
I addressed the students of the first batch of BIMTECH Bhubaneshawar in Greater NOIDA on Jan 04, 2014. While the topic was Using PowerPoint, I went beyond the software to cover fundamentals about the attention span of audience, why reading from slides leads to fragmented learning. I emphasised that PowerPoint is a tool and its more important to understand the art and then use the software in all its power (no pun intended.)TRANSCRIPT
Lets Learn SomePowerPoint
Mohit Chhabra!mohit_chhabra
#pptevangelist
PowerPoint is Evil!
Sep 2003
Edward Tufte Data Visualization Pioneer Professor, Yale University
Ubiquitous
Class Room
RoomBoard
RoomWar
Necessary Evil
Evil
Container of Ideas
Shoot-the-Messenger Syndrome
PowerPointDeath by
&Best
WorstPresentations
WHY?WHY?
Lack of Preparation
PowerPointDeath by
PowerPointDeath by
Lets get active
What is a Presentation? !
Inform
Persuade
Entertain
Conversations
Persuade Inform
Persuade Inform
Persuade Inform
Text
TextVoice
TextVoice
TextVoice
Split Attention Effect
TextVoice
Split Attention Effect
PowerPoint Skills
PowerPoint Skills
PowerPoint Skills
Learning to create better graphics in PowerPoint for amplifying your
message
Complete sentence.3things
Subject. Learning to create better graphics3things
Verb. (Amplifying your message)
3things
WHY?WHY?
Audiences remember very few things
Data, Figures, Pictures, Text
Fragmented Retention
Big Idea
Strengthen
Graphs & Tables
Pictures
Diagrams
Progression
Graphs & Tables
US$ 0
US$ 1,50,000
US$ 3,00,000
US$ 4,50,000
US$ 6,00,000Ju
ly
Aug
ust
Sept
embe
r
Oct
ober
Nov
embe
r
Dec
embe
r
Pharma APharma BPharma CPharma DPharma EPharma FPharma GPharma HPharma I
Sales Compared to Competitors
0
150
300
450
600
0
150
300
450
600
July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec
Pharma A Pharma D
Pharma G Pharma H
Note: All figures in $ ‘000
Sales Compared
0
150
300
450
600
0
150
300
450
600
July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec
Pharma A Pharma D
Pharma G Pharma H
Note: All figures in $ ‘000
Average Pharma E
Sales Compared
0
150
300
450
600
0
150
300
450
600
A D G H E A D G H E A D G H E
Oct 2012 Nov 2012 Dec 2012
July 2012 Aug 2012 Sep 2012
Note: All figures in $ ‘000
Sales Compared
0
150
300
450
600
295
110
390
565
140
245
100
375
550
142
145
95
390390
153
0
150
300
450
600
A D G H E
255
90
385
570
188
A D G H E
190
80
460465
185
A D G H E
262
65
550570
200
Oct 2012 Nov 2012 Dec 2012
July 2012 Aug 2012 Sep 2012
Note: All figures in $ ‘000
Unable to Gain Traction
How much bigger is the large circle than the small circle?
16
Pharma HPharma GPharma F
Pharma E
Pharma D
Pharma C
Pharma B
Pharma A
Market Share
Pharma H 1%
Pharma G 4%Pharma F
7%
Pharma E 8%
Pharma D 10%
Pharma C 10%
Pharma B 28%
Pharma A 33%
Market Share
Market Share
Market Share at the end of 2012
A
Our Co.
C
D
E
F
G
H 1
4
7
8
10
10
28
33
Note: All figures in percent
Market Share at the end of 2012
A
Our Co.
C
D
E
Others
Note: All figures in percent
73%
Purpo
se
Analyzing
Purpo
se
Analyzing
Monitoring
Purpo
se
Analyzing
Monitoring
Purpo
sePlanning
Analyzing
Monitoring
Purpo
sePlanning
Communicating
What would you like to show?
What would you like to show?
Distribution
What would you like to show?
Distribution
Composition
What would you like to show?
Distribution
Relationship
Composition
What would you like to show?
Distribution
Relationship
CompositionComparison
Select the appropriate statistical data
‣ To show composition, usually
‣ To show composition, usually
‣ 4 – 6 slices
‣ To show composition, usually !
‣ 4 – 6 slices !
‣ Contrast with color or by exploding (or both!)
‣ To show comparison
‣ To show comparison
‣ Best used for a few periods of time
‣ To show comparison
‣ Best used for a few periods of time
‣ Best if you limit the bars to 4-6
Used to demonstrate trends
‣ To show comparison
‣ To show comparison
Rs
Year 1 Year 2 Year 3
REVENUES 4,02,66,240 4,40,02,560 4,69,32,480
EXPENSES
Manpower 1,24,92,000 1,37,41,200 1,51,15,320
Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204
Depreciation 18,24,000 10,94,400 6,56,640
Software cost amortized 2,95,50,000 0 0
Total 4,91,78,400 2,66,64,440 2,82,79,164
Losses carried forward -89,12,160
EBIT -89,12,160 84,25,960 1,86,53,316
Manpower (%age) 31% 31% 32%
EBIT (%age) -22% 19% 40%
Rs
Year 1 Year 2 Year 3
REVENUES 4,02,66,240 4,40,02,560 4,69,32,480
EXPENSES
Manpower 1,24,92,000 1,37,41,200 1,51,15,320
Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204
Depreciation 18,24,000 10,94,400 6,56,640
Software cost amortized 2,95,50,000 0 0
Total 4,91,78,400 2,66,64,440 2,82,79,164
Losses carried forward -89,12,160
EBIT -89,12,160 84,25,960 1,86,53,316
Manpower (%age) 31% 31% 32%
EBIT (%age) -22% 19% 40%
!
!
Too Detailed! !
Rs (lakh)
Year 1 Year 2 Year 3
REVENUES 403 440 469
EXPENSES
Manpower 125 137 151
Total Operating Expenses 53 118 125
Depreciation 18 11 7
Software cost amortised 296 0 0
Total 492 267 283
Losses carried forward -89
EBIT -89 84 187
Manpower (as a %age) 31% 31% 32%
EBIT (as a %age) -22% 19% 40%
Rs (lakh)
Year 1 Year 2 Year 3
REVENUES 403 440 469
EXPENSES
Manpower 125 137 151
Total Operating Expenses 53 118 125
Depreciation 18 11 7
Software cost amortised 296 0 0
Total 492 267 283
Losses carried forward -89
EBIT -89 84 187
Manpower (as a %age) 31% 31% 32%
EBIT (as a %age) -22% 19% 40%
!
!
Much Better! !
Rs (lakh)
Year 1 Year 2 Year 3
REVENUES 403 440 469
EXPENSES
Manpower 125 137 151
Total Operating Expenses 53 118 125
Depreciation 18 11 7
Software cost amortised 296 0 0
Total 492 267 283
Losses carried forward -89
EBIT -89 84 187
Manpower (as a %age) 31% 31% 32%
EBIT (as a %age) -22% 19% 40%
When the numbers are more important than the relationship
!
!
Much Better! !
Data should be stripped to the
ESSENTIALS
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
0
83
167
250
333
417
500
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Revenue This Quarter
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Q3 ’13 Revenues (in Rs lakh)
Source: Internal
Recap
Removed backgrounds
Removed extra labels
Removed borders and lines
Removed shadows, colors and effects
Simplified labels and title
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Q3 ’13 Revenues (in Rs lakh)
Source: Internal
Data to Inkratio
Data to Inkratio
INCREASE
Pictures
Lasting Partnerships
Partnerships Against All Odds
Text
Security!
Diagrams
1 Network
1 Network
1 Network
2 Segment
2 Segment
3 Flow
3 Flow
3 Flow
3 Flow
4 Join
4 Join
5 Stack
5 Stack
5 Stack
Progression
Revenue This QuarterVa
lue
In R
s la
kh
0
83
167
250
333
417
500
Product
Supra Microg Gemna Hylar Elexso
190
80
460465
185
SupraMicrogGemnaHylarElexso
Supra Microg Gemna Hylar Elexso
190
80
460465
185
Q3 ’13 Revenues (in Rs lakh)
Source: Internal
15 slides
Disruptive Technology
Time
Perf
orm
ance
Sustaining Technology
Performance improvement demanded
t
Performance Oversupply
Current performance of potentially disruptive technologyExpected tra
jectory of improvement
The sustaining technology has been disrupted
Disruptive Technology
Time
Perf
orm
ance
Sustaining Technology
Performance improvement demanded
t
Performance Oversupply
Current performance of potentially disruptive technologyExpected tra
jectory of improvement
The sustaining technology has been disrupted
Too
Cluttered
Disruptive Technology
Time
Perf
orm
ance
Disruptive Technology
Time
Perf
orm
ance
Disruptive Technology
Time
Perf
orm
ance
Sustaining Technology
Disruptive Technology
Time
Perf
orm
ance
Sustaining Technology
Disruptive Technology
Time
Perf
orm
ance
Sustaining Technology
Performance improvement demanded
Disruptive Technology
Time
Perf
orm
ance
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
Performance Oversupply
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
Current performance of potentially disruptive technology
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
Expected trajectory of im
provement
Disruptive Technology
Time
Perf
orm
ance
t
Disruptive Technology
Time
Perf
orm
ance
t
The sustaining technology has been disrupted
This is Tom Peters and he is very intelligent!
Tom Peters
You can use his quotes in your presentations!
Is it Actionable?
Is it Actionable? N
O
O DELETE it!
O DELETE it!Archive it!
DELETE it!Archive it!
O
Is it Actionable? N
Is it Actionable?
YES
.
.DEFER it!
.DEFER it!
DELEGATE it!
.
DELEGATE it!
.
.DO it!
.DO it!
Immediately
.DO it!
Immediately
To Do List
mohitchhabra
mohit_chhabra
mohitchhabra
"
!
!@